A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.

Clinical trial NCT05644600 · TERMINATED

Trial details

NCT number: NCT05644600
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2023-05-26
Primary completion: 2023-07-17
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.